# Horizon Kinetics Medical ETF (MEDX): ETF Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/medx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: Horizon Kinetics · Asset class: Equity - Strategy: Passive Index · Inception: 2023-01-27 Listed Funds Trust - Horizon Kinetics Medical ETF is an exchange traded fund launched by Listed Funds Trust. The fund is managed by Horizon Kinetics Asset Management LLC. The fund invests in public equity markets of global region. It invests in stocks of companies operating across healthcare, healthcare equipment and services, healthcare equipment and supplies, healthcare equipment, medical equipment, surgical and laboratory sterilizers, healthcare providers and services, health care services, medical laboratory services, medical research laboratory services, pharmaceuticals, biotechnology... ## Key Facts | Metric | Value | |---|---| | Price | $36.53 | | Expense Ratio | 0.85% | | Assets Under Management | $17.2M | | NAV | $36.49 | | Holdings Count | 32 | | Distribution Yield (TTM) | 1.12% | | Annual Distribution (TTM) | $0.41 /share | | Distribution Frequency | Annual | | 52-Week Range | $30.79 – $37.90 | | Beta | 0.52 | ## Latest Distribution - Amount: $0.4088 /share - Ex-date: 2025-12-23 - Pay date: 2025-12-24 ## Frequently Asked Questions ### What does MEDX invest in? Listed Funds Trust - Horizon Kinetics Medical ETF is an exchange traded fund launched by Listed Funds Trust. The fund is managed by Horizon Kinetics Asset Management LLC. The fund invests in public equity markets of global region. It invests in stocks of companies operating across healthcare, healthcare equipment and services, healthcare equipment and supplies, healthcare equipment, medical equipment, surgical and laboratory sterilizers, healthcare providers and services, health care services, medical laboratory services, medical research laboratory services, pharmaceuticals, biotechnology and life science sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to benchmark the performance of its portfolio against the S&P 500 TR Index. Listed Funds Trust - Horizon Kinetics Medical ETF was formed on September 30, 1999 and is domiciled in the United States. ### What is the expense ratio of MEDX? Horizon Kinetics Medical ETF (MEDX) charges an expense ratio of 0.85%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is MEDX? Horizon Kinetics Medical ETF (MEDX) manages $17.2M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is MEDX actively managed or an index fund? MEDX is a passive index fund. It tracks a published benchmark by holding the constituents in their published weights. Index funds typically charge low expense ratios (MEDX's is 0.85%) because there's no security selection cost. ### When was MEDX launched? Horizon Kinetics Medical ETF (MEDX) launched in January 2023 and is managed by Horizon Kinetics. ### How has MEDX performed? MEDX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does MEDX pay a dividend? Horizon Kinetics Medical ETF (MEDX) currently distributes little or no income. Trailing-twelve-month yield is 1.12%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does MEDX pay dividends? Horizon Kinetics Medical ETF pays dividends Annual. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is MEDX's dividend yield? MEDX's trailing-twelve-month yield is 1.12%, calculated from the sum of dividends over the past year divided by the current price. ### When is MEDX's next ex-dividend date? The most recently announced ex-dividend date for MEDX was 2025-12-23. The next ex-date typically follows Annual; once announced it appears at the top of the dividend history table on this page. ### How much will MEDX's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 0.85% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does MEDX charge its expense ratio? The expense ratio is deducted in tiny daily slices from MEDX's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does MEDX cost more than a fund like VOO? MEDX is a passive index fund (current expense ratio 0.85%). Differences from broad-market ETFs like VOO usually come from index licensing fees, asset class (bond funds typically run cheaper than equity), or fund scale (smaller funds spread fixed operating costs across less AUM). ### Are there cheaper alternatives to MEDX? The Lower-Fee Alternatives card above lists ETFs following the same investment strategy as MEDX (0.85%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/medx - Distribution history: https://www.dividenddata.com/funds/medx/dividend - Holdings & diversification: https://www.dividenddata.com/funds/medx/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/medx/expenses - Peer comparison: https://www.dividenddata.com/funds/medx/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.